Literature DB >> 26064327

Inhibition of mouse B16 melanoma by sodium butyrate correlated to tumor associated macrophages differentiation suppression.

Fen Xiong1, Yun-Zhu Mou1, Xiao-Yan Xiang2.   

Abstract

OBJECTIVE: As one member of the histone deacetylase inhibitor (HDACi) family, Sodium butyrate (NaB) was found out that could be used as a differentiation inducer of much cancer cell. But its effects on tumor microenvironment cells are not well recognized. The goal of this research is to investigate the effect of NaB on B16 melanoma and analysis its relevant mechanism.
METHODS: We observed the effect of sodium butyrate on B16 melanoma in vivo and in vitro. MTT method was performed to detect cell apoptosis rate after treatment. Tumor associated macrophage infiltration condition was detected by flow cytometry. Western-blotting and immunohistochemical method were used to detect the expression of tumor associated macrophage cytokines.
RESULTS: A certain concentration of sodium butyrate could effectively inhibit B16 melanoma growth in vivo and in vitro, and this inhibition effects related to the suppression of tumor associated macrophage differentiation. At the same time we observed the relevant macrophage factors were down-regulated compared to the control.
CONCLUSION: Sodium butyrate could effectively inhibit B16 melanoma growth through suppressing tumor associated macrophage proliferation and reduce relevant pro-tumor macrophage factors expression, which may help to promote the clinical study of melanoma epigenetic therapy.

Entities:  

Keywords:  B16; Sodium butyrate (NaB); TAMs

Year:  2015        PMID: 26064327      PMCID: PMC4443161     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  15 in total

1.  Trastuzumab enhances the anti-tumor effects of the histone deacetylase inhibitor sodium butyrate on a HER2-overexpressing breast cancer cell line.

Authors:  Weiwei Chen; Feng Wei; Jing Xu; Yucai Wang; Longbang Chen; Jinghua Wang; Xiaoxiang Guan
Journal:  Int J Mol Med       Date:  2011-09-01       Impact factor: 4.101

Review 2.  Regulation of apoptosis-associated genes by histone deacetylase inhibitors: implications in cancer therapy.

Authors:  Ali R Jazirehi
Journal:  Anticancer Drugs       Date:  2010-10       Impact factor: 2.248

Review 3.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

Authors:  Alberto Mantovani; Silvano Sozzani; Massimo Locati; Paola Allavena; Antonio Sica
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

Review 4.  Clinical development of histone deacetylase inhibitors as anticancer agents.

Authors:  Daryl C Drummond; Charles O Noble; Dmitri B Kirpotin; Zexiong Guo; Gary K Scott; Christopher C Benz
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

5.  Overexpression of histone deacetylase 1 confers resistance to sodium butyrate-mediated apoptosis in melanoma cells through a p53-mediated pathway.

Authors:  Debdutta Bandyopadhyay; Anupam Mishra; Estela E Medrano
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

6.  Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.

Authors:  Victor Sandor; Susan Bakke; Robert W Robey; Min H Kang; Mikhail V Blagosklonny; Jonathon Bender; Rebecca Brooks; Richard L Piekarz; Eben Tucker; William D Figg; Kenneth K Chan; Barry Goldspiel; Antonio Tito Fojo; Stanley P Balcerzak; Susan E Bates
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

7.  DMSO reduces CSF-1 receptor levels and causes apoptosis in v-myc immortalized mouse macrophages.

Authors:  P Marthyn; A Beuscart; J Coll; F Moreau-Gachelin; M Righi
Journal:  Exp Cell Res       Date:  1998-08-25       Impact factor: 3.905

8.  Induction by dimethyl sulfoxide of Fc fragment-mediated phagocytosis in the mouse macrophage-like cell line P388D1.

Authors:  S Takasaki; L Leive
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

9.  Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells.

Authors:  Young-Ho Kim; Jong-Wook Park; Jai-Youl Lee; Taeg Kyu Kwon
Journal:  Carcinogenesis       Date:  2004-05-13       Impact factor: 4.944

10.  Deacetylase inhibition in malignant melanomas: impact on cell cycle regulation and survival.

Authors:  Vivi Ann Flørenes; Martina Skrede; Kjersti Jørgensen; Jahn M Nesland
Journal:  Melanoma Res       Date:  2004-06       Impact factor: 3.599

View more
  6 in total

Review 1.  Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises.

Authors:  Nikolaos Garmpis; Christos Damaskos; Anna Garmpi; Emmanouil Kalampokas; Theodoros Kalampokas; Eleftherios Spartalis; Afrodite Daskalopoulou; Serena Valsami; Michael Kontos; Afroditi Nonni; Konstantinos Kontzoglou; Despina Perrea; Nikolaos Nikiteas; Dimitrios Dimitroulis
Journal:  Cancer Genomics Proteomics       Date:  2017 Sep-Oct       Impact factor: 4.069

2.  Histone deacetylase inhibitor NaBut suppresses cell proliferation and induces apoptosis by targeting p21 in multiple myeloma.

Authors:  Ruosi Yao; Danyang Han; Xiaoyang Sun; Chunling Fu; Qingyun Wu; Yao Yao; Hujun Li; Zhenyu Li; Kailin Xu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 3.  Adjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate Vaccination.

Authors:  Lakshmi Jayashankar; Richard Hafner
Journal:  Front Immunol       Date:  2016-12-16       Impact factor: 7.561

4.  Butyric Acid from Probiotic Staphylococcus epidermidis in the Skin Microbiome Down-Regulates the Ultraviolet-Induced Pro-Inflammatory IL-6 Cytokine via Short-Chain Fatty Acid Receptor.

Authors:  Sunita Keshari; Arun Balasubramaniam; Binderiya Myagmardoloonjin; Deron Raymond Herr; Indira Putri Negari; Chun-Ming Huang
Journal:  Int J Mol Sci       Date:  2019-09-11       Impact factor: 5.923

5.  Icariin induces cell differentiation and cell cycle arrest in mouse melanoma B16 cells via Erk1/2-p38-JNK-dependent pathway.

Authors:  Dan Wang; Wenjuan Xu; Xiaoyu Chen; Jichun Han; Lina Yu; Caixia Gao; Wenjin Hao; Xiaona Liu; Qiusheng Zheng; Defang Li
Journal:  Oncotarget       Date:  2017-08-10

6.  Comparative cell biological study of in vitro antitumor and antimetastatic activity on melanoma cells of GnRH-III-containing conjugates modified with short-chain fatty acids.

Authors:  Eszter Lajkó; Sarah Spring; Rózsa Hegedüs; Beáta Biri-Kovács; Sven Ingebrandt; Gábor Mező; László Kőhidai
Journal:  Beilstein J Org Chem       Date:  2018-09-26       Impact factor: 2.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.